The sensitivity analyses, which assessed HIF-1α positivity based on percent positive of tumor cells, yielded similar results to the analyses assessing HIF-1α expression based on the H-score (Additional file 1: Tables S2–S6). This evidence concerns the gene HIF1A and neoplasm.